ICE-HBV Symposium
7th annual ICE-HBV HBV cure symposium
Therapeutic Vaccines for Chronic Hepatitis B: Optimizing Their Utility in Novel Therapeutic Combinations
Chairs: Adam J. Gehring [Canada] and Anna D. Kosinska [Germany]
Sept. 6 at 3:00 to 6:00 p.m. SST | Singapore
| 3:00 - 3:10 |
Welcome address Speaker: Adam Gehring |
| 3:10 - 3:35 |
What we’ve learned, current strategies and future prospects for therapeutic vaccines. Speaker: Anna Kosinska |
| 3:35 – 4:00 |
Vaccine combinations in the current landscape of novel HBV therapies Speaker: Seng Gee Lim |
| 4:00 – 4:25 |
Does antigen reduction impact immunogenicity of therapeutic vaccines? Speaker: Antonio Bertoletti |
| 4:25 – 4:45 |
Coffee break |
| 4:45 – 5:05 |
How much would effective therapeutic vaccination improve functional cure rates? Speaker: Adam Gehring |
| 5:05 – 5:15 |
TherVacB - on the way to the clinic Speaker: Ulrike Protzer |
| 5:15 – 5:25 |
Immunogenicity of GS-2829 and GS-6779 in CHB patients with a broad range of baseline HBsAg levels. Speaker: Simon Fletcher |
| 5:25 – 5:35 |
Immunogenicity and long-term antiviral effect of VRON-0200 Speaker: Sue Currie |
| 5:35 – 6:00 |
Round table discussion |
General Public ICE-HBV Symposium Registration
The ICE-HBV Symposium will take place on Sept. 6, 2026. If you are a member of the public who does not wish to register for the main HBV Meeting but would like to register for the ICE-HBV Symposium, please click here.